BeOne Medicines Ltd. 4

BeOne Medicines Ltd. CFO Aaron Rosenberg sold 1,157 American Depositary Shares on August 3, 2026 for roughly $362K to cover taxes tied to RSU vesting.

On August 3, 2026, BeOne Medicines Ltd. Chief Financial Officer Aaron Rosenberg disposed of 1,157 American Depositary Shares (each ADS representing 13 Ordinary Shares) at an average price of approximately $312.715 per ADS, for a total value of about $361,800, in a transaction classified as a sale. According to the Form 4 footnote, the sale was executed solely to satisfy mandatory tax withholding obligations arising from the vesting of a previously granted restricted share unit award, with 1/4 of the award vesting annually on each anniversary of July 31, 2024, subject to continued service and with provision for accelerated vesting upon certain termination events. After the transaction, Rosenberg continues to beneficially own a substantial equity position in BeOne Medicines’ Ordinary Shares, with the remaining holdings’ value inferred using the same transaction price context, indicating this was a routine tax-related disposition rather than a discretionary open‑market sale.

Filing Facts

CIK

1651308

Ticker

ONC

Form

4

Source Type

fda

Accession

0002031182-26-000005

Alert Tier

6